Studies related to Uric Acid and Vitamin B2

Riboflavin Supplementation And Biomarkers Of Cardiovascular Disease In The Elderly

Effect None
Trial Design Double blind
Trial Length 2-4 Weeks
Number of Subjects 42
Sex Both Genders
Age Range 45-64, 65+
Body Types Overweight
Notes for this study:
Four weeks supplementation of 10mg riboflavin supplementation in elderly subjects with suboptimal riboflavin status (assessed by EGRAC) was able to reduce total homocysteine levels in serum, but was without effect on C-reactive protein or other biomarkers of cardiovascular health.